Drug Discovery Informatics Market

Q: How big was the global drug discovery informatics market in 2025?

It was valued at US$ 4.8 Bn in 2025 Read More

Q: Which was the major region in the global drug discovery informatics landscape in 2025?

North America was the leading region in 2025 Read More

Drug Discovery Informatics Market (Product: Discovery Informatics and Development Informatics; and Mode: In-house Informatics and Outsourced Informatics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026-2036

Drug Discovery Informatics Market Outlook 2036

The global industry was valued at US$ 4.8 Bn in 2025
It is estimated to advance at a CAGR of 10.8% from 2026 to 2036 and reach US$ 15.1 Bn by the end of 2036

Drug Discovery Informatics Market By Region

Analyst Viewpoint

Surge in R&D investment in the pharmaceutical sector is a key factor that is fostering drug discovery informatics market development. Data-driven software and techniques offer assistance to researchers by optimizing the drug design and development process. They help in pre-clinical research, drug target identification, and prediction of drug resistance and side effects. Advancements in data science such as sophisticated data analytics and machine learning tools are also propelling drug discovery informatics industry size.

Critical research of conventional methods of drug development makes up for the majority of the R&D expenditure of big pharmaceutical firms. Prominent players in the global drug discovery informatics market are investing significantly in AI-driven drug discovery innovations. They are also using novel data-driven tools for digital transformation of the healthcare sector.

Drug Discovery Informatics Market Overview

Drug discovery informatics entails the adoption of information technology to assist researchers in drug discovery and creation process. The process requires the usage of computational methods and tools such as Artificial Intelligence and advanced software to analyze large sets of biochemical data in order to identify possible drug candidates.

Drug discovery is a time and resource-draining initiative that involves isolating and fostering a compound that shows signs of treating an infection in a meaningful way A developed drug has to further meet strict health and safety regulations to be deemed safe and adequate for administration.

Individual bioinformatics tools and databases are constantly being updated to allow for the optimization of the drug discovery process, as vast sets of biological, chemical, and toxicological data can be analyzed to assist in novel drug development.

Surge in R&D Investment in Pharmaceutical Sector Augmenting Drug Discovery Informatics Market Growth

Pharmaceutical companies rely on data-driven informatics software to assist them in pre-clinical research, lead identification, and compound screening. They use this data to identify patterns, test theories, and understand the efficacy of treatments. Companies are investing significantly in R&D cycle of new drugs.

Global pharmaceutical companies are substantially increasing investment in research and development as drug discovery becomes more complex and data intensive. According to Evaluate Pharma, worldwide pharmaceutical R&D spending reached approximately US$306 Bn in 2024, compared with around US$258 Bn in 2022. Global pharmaceutical R&D expenditure is projected to increase further to approximately US$366 Bn by 2030.

Rising R&D expenditure is encouraging pharmaceutical and biotechnology companies to strengthen their digital research infrastructure and integrate genomic, chemical, clinical, and real-world datasets. Drug discovery informatics platforms enable researchers to centralize and standardize large volumes of scientific data, improve compound screening and target identification, and support predictive modeling. Well-structured and interoperable datasets also provide the foundation required to effectively deploy artificial intelligence and machine learning across drug discovery workflows.

The growing application of AI further strengthens the need for advanced informatics infrastructure. According to the Information Technology and Innovation Foundation (ITIF), AI has the potential to improve productivity across the drug-development pipeline and early evidence indicates that it could reduce drug-development timelines by roughly 50%. ITIF also notes that development of a new drug can require more than US$2.8 Bn in R&D expenditure, highlighting the substantial economic incentive to improve discovery productivity. AI-enabled platforms can accelerate target identification, optimize candidate selection, improve clinical-trial design, and reduce repetitive experimental work.

Consequently, continued growth in pharmaceutical R&D spending, combined with increasing adoption of AI, machine learning, predictive analytics, and integrated scientific data platforms, is expected to drive demand for drug discovery informatics solutions.

Advancements in Data Science Fueling Market Progress

Rapid advancements in data science, artificial intelligence (AI), machine learning (ML), and predictive analytics are transforming pharmaceutical drug discovery. These technologies enable researchers to analyze large and complex biological and chemical datasets, identify previously undetected relationships, prioritize therapeutic targets, predict molecular properties, and screen potential drug candidates more efficiently. Their integration can therefore reduce repetitive experimental work and improve decision-making across early-stage discovery.

The Stanford University 2026 AI Index Report highlights the accelerating application of AI across biological sciences. AI-related publications in the natural sciences reached approximately 80,150 in 2025, up 26% from 2024. Stanford also reported that virtual cell models emerged as an important frontier in 2025, with new models designed to predict cellular responses to drugs and genetic perturbations without initially requiring wet-lab experiments. The report further notes that biological AI development is increasingly constrained by the availability and quality of data, emphasizing the importance of integrated, standardized, and well-managed scientific datasets.

Growing volumes of genomic, proteomic, phenotypic, chemical, and clinical data are consequently increasing demand for sophisticated drug discovery informatics platforms. AI and ML can combine these datasets to support target identification and validation, molecular simulation, structure prediction, virtual screening, drug-response prediction, toxicity assessment, and biomarker discovery. Advances in protein and genomic modeling are also improving researchers' ability to understand disease mechanisms and interactions among proteins, nucleic acids, and small molecules.

The commercial relevance of these technologies is becoming increasingly evident. In 2025, an AI-discovered drug and target combination reached a randomized Phase 2a clinical trial for idiopathic pulmonary fibrosis, representing an important milestone in the clinical translation of AI-enabled drug discovery. At the same time, conventional drug-development programs can take more than 12 years, cost approximately US$2.5 Bn, and experience failure rates exceeding 90%, creating strong incentives for pharmaceutical and biotechnology companies to adopt informatics and machine-learning approaches that improve candidate selection and reduce costly failures.

Thus, increasing availability of biomedical data, improvements in AI models, and the shift toward computational and data-driven drug discovery are expected to accelerate adoption of drug discovery informatics solutions. These platforms are becoming increasingly important for shortening discovery timelines, improving R&D productivity, supporting precision medicine, and advancing promising therapeutic candidates toward clinical development.

Regional Outlook

According to a recent drug discovery informatics market analysis, North America accounted for the largest share of the global market in 2025. Presence of a well-developed healthcare sector, rise in awareness about drug testing, and R&D of progressive drug discovery solutions are augmenting the market dynamics of the region.

U.S. pharmaceutical expenditure continues to rise significantly, reflecting the scale and maturity of the country's pharmaceutical ecosystem. According to the American Society of Health-System Pharmacists (ASHP) and the American Journal of Health-System Pharmacy, total U.S. prescription drug expenditures reached approximately US$ 915.2 Bn in 2025, increasing 12.7% from 2024. Overall expenditure is projected to grow another 10%-12% in 2026 and exceed US$1.0 Trn for the first time. Rising pharmaceutical expenditure, coupled with substantial R&D activity and adoption of computational technologies, supports continued investment in drug discovery and informatics infrastructure.

Asia Pacific is emerging as the fastest-growing regional market for drug discovery informatics, supported by expansion of pharmaceutical and biotechnology R&D, increasing drug-development outsourcing, growth of contract research organizations (CROs), and greater adoption of artificial intelligence, cloud computing, bioinformatics, and computational drug-design platforms. China, India, Japan, South Korea, and other regional markets are strengthening domestic drug-discovery capabilities and investing in data-driven research infrastructure. Current market estimates indicate that the Asia Pacific drug discovery informatics market is expected to expand at approximately 14.0% CAGR through 2036, faster than other major regions.

India represents an important part of this regional pharmaceutical and biotechnology ecosystem. According to the Government of India, India is the world's largest vaccine producer and supplies approximately 60% of global vaccines. The country is also a major supplier to international immunization programs and accounts for approximately 55%-60% of UNICEF's vaccine procurement volumes. India's large vaccine, generic pharmaceutical, biotechnology, and contract research industries, combined with increasing emphasis on indigenous drug development, biologics, biosimilars, and advanced R&D, are creating a favorable environment for greater adoption of drug discovery informatics platforms.

Analysis of Key Players

According to recent drug discovery informatics market trends, prominent manufacturers are investing substantially in the development of pharmaceutical informatics and computational drug discovery technologies. They are carrying out advancements in conventional drug testing to resolve critical issues for both patients and healthcare workers.

Charles River Laboratories International, Inc., Thermo Fisher Scientific, Inc., Revvity, Inc., Dotmatics, Dassault Systèmes SE / BIOVIA, Insilico Medicine, Inc., Collaborative Drug Discovery, Inc., Schrödinger, Inc., Curia Global, Inc., Certara, Inc. are key firms that account for significant drug discovery informatics market share.

The drug discovery informatics market report highlights the leading companies in the global landscape in terms of parameters such as company overview, business strategies, product portfolio, financial overview, and business segments.

Key Developments

In September 2026, Iktos and Pierre Fabre Laboratories entered into an integrated drug discovery collaboration to identify and develop novel small-molecule oncology candidates. Under the agreement, Iktos will deploy its AI-driven generative molecular design platform, while Pierre Fabre will contribute oncology research, biology, medicinal expertise, and preclinical-development capabilities to evaluate and advance selected candidates.
In July 2026, Insilico Medicine initiated a Phase III clinical trial of rentosertib, its AI-empowered TNIK inhibitor for idiopathic pulmonary fibrosis. The candidate originated from Insilico's Pharma.AI platform, with both the therapeutic target and molecule developed using AI-supported discovery approaches. The advancement into Phase III represents a major clinical milestone for AI-enabled drug discovery.

Drug Discovery Informatics Market Snapshot

Attribute	Detail
Market Value in 2025 (Base Year)	US$ 4.8 Bn
Market Forecast Value in 2036	US$ 15.1 Bn
Growth Rate (CAGR)	10.8%
Forecast Period	2026-2036
Historical Data Available for	2021-2025
Quantitative Units	US$ Bn for Value
Drug Discovery Informatics Market Analysis	Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis.
Competition Landscape	Prominent Players - Competition Dashboard and Revenue Share Analysis, 2025 Company Profiles (Details - Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
Format	Electronic (PDF) + Excel
Regions Covered	North America Asia Pacific Europe Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Spain Italy Japan China India Australia & New Zealand Brazil Mexico GCC Countries South Africa
Market Segmentation	Product Discovery Informatics Development Informatics Mode In-house Informatics Outsourced Informatics Function Sequencing and Target Data Analysis Docking Lead Generation Informatics Identification and Validation Informatics Molecular Modeling Others End-user Pharmaceutical and Biotechnology Companies Contract Research Organizations Others
Companies Profiled	Charles River Laboratories International, Inc. Thermo Fisher Scientific, Inc. Revvity, Inc. Dotmatics Dassault Systèmes SE / BIOVIA Insilico Medicine, Inc. Collaborative Drug Discovery, Inc. Schrödinger, Inc. Curia Global, Inc. Certara, Inc. Other Players
Customization Scope	Available upon Request
Pricing	Available upon Request

Frequently Asked Questions

How big was the global drug discovery informatics market in 2025?

It was valued at US$ 4.8 Bn in 2025

How is the drug discovery informatics industry business expected to grow by 2036?

It is projected to advance at a CAGR of 10.8% from 2026 to 2036

What are the key factors driving the demand for drug discovery informatics?

Surge in R&D investment in the pharmaceutical sector and advancements in data science

Which drug discovery informatics function segment held the largest share in 2025?

The sequencing and target data analysis function segment constituted the largest share in 2025

Which was the major region in the global drug discovery informatics landscape in 2025?

North America was the leading region in 2025

Who are the key drug discovery informatics manufacturers?

Preface
- Market Definition and Scope
- Market Segmentation
- Key Research Objectives
- Research Highlights
Assumptions and Research Methodology
Executive Summary: Global Drug Discovery Informatics Market
Market Overview
- Introduction
  - Segment Definitions
  - Industry Evolution / Developments
- Overview
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Global Drug Discovery Informatics Market Analysis and Forecast, 2026-2036
Key Insights
- Pipeline Analysis
- Key Product/Brand Analysis
- Key Mergers & Acquisitions
- COVID-19 Pandemic Impact on Industry
Global Drug Discovery Informatics Market Analysis and Forecast, by Product
- Introduction and Definitions
- Key Findings/Developments
- Market Value Forecast, by Product, 2021-2036
  - Discovery Informatics
  - Development Informatics
- Market Attractiveness, by Product
Global Drug Discovery Informatics Market Analysis and Forecast, by Mode
- Introduction and Definitions
- Key Findings/Developments
- Market Value Forecast, by Mode, 2021-2036
  - In-house Informatics
  - Outsourced Informatics
- Market Attractiveness, by Mode
Global Drug Discovery Informatics Market Analysis and Forecast, by Function
- Introduction and Definitions
- Key Findings/Developments
- Market Value Forecast, by Function, 2021-2036
  - Sequencing and Target Data Analysis
  - Docking
  - Lead Generation Informatics
  - Identification and Validation Informatics
  - Molecular Modeling
  - Others
- Market Attractiveness, by Function
Global Drug Discovery Informatics Market Analysis and Forecast, by End-user
- Introduction and Definitions
- Key Findings/Developments
- Market Value Forecast, by End-user, 2021-2036
  - Pharmaceutical and Biotechnology Companies
  - Contract Research Organizations
  - Others
- Market Attractiveness, by End-user
Global Drug Discovery Informatics Market Analysis and Forecast, by Region
- Key Findings
- Market Value Forecast, by Region, 2021-2036
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East & Africa
- Market Attractiveness, by Region
North America Drug Discovery Informatics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product, 2021-2036
  - Discovery Informatics
  - Development Informatics
- Market Attractiveness, by Product
- Market Value Forecast, by Mode, 2021-2036
  - In-house Informatics
  - Outsourced Informatics
- Market Attractiveness, by Mode
- Market Value Forecast, by Function, 2021-2036
  - Sequencing and Target Data Analysis
  - Docking
  - Lead Generation Informatics
  - Identification and Validation Informatics
  - Molecular Modeling
  - Others
- Market Attractiveness, by Function
- Market Value Forecast, by End-user
  - Pharmaceutical and Biotechnology Companies
  - Contract Research Organizations
  - Others
- Market Attractiveness, by End-user
- Market Value Forecast, by Country, 2021-2036
  - U.S.
  - Canada
- Market Attractiveness Analysis
  - By Product
  - By Mode
  - By Function
  - By End-user
  - By Country
Europe Drug Discovery Informatics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product, 2021-2036
  - Discovery Informatics
  - Development Informatics
- Market Attractiveness, by Product
- Market Value Forecast, by Mode, 2021-2036
  - In-house Informatics
  - Outsourced Informatics
- Market Attractiveness, by Mode
- Market Value Forecast, by Function, 2021-2036
  - Sequencing and Target Data Analysis
  - Docking
  - Lead Generation Informatics
  - Identification and Validation Informatics
  - Molecular Modeling
  - Others
- Market Attractiveness, by Function
- Market Value Forecast, by End-user, 2021-2036
  - Pharmaceutical and Biotechnology Companies
  - Contract Research Organizations
  - Others
- Market Attractiveness, by End-user
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Rest of Europe
- Market Attractiveness Analysis
  - By Product
  - By Mode
  - By Function
  - By End-user
  - By Country/Sub-region
Asia Pacific Drug Discovery Informatics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product, 2021-2036
  - Discovery Informatics
  - Development Informatics
- Market Attractiveness, by Product
- Market Value Forecast, by Mode, 2021-2036
  - In-house Informatics
  - Outsourced Informatics
- Market Attractiveness, by Mode
- Market Value Forecast, by Function, 2021-2036
  - Sequencing and Target Data Analysis
  - Docking
  - Lead Generation Informatics
  - Identification and Validation Informatics
  - Molecular Modeling
  - Others
- Market Attractiveness, by Function
- Market Value Forecast, by End-user, 2021-2036
  - Pharmaceutical and Biotechnology Companies
  - Contract Research Organizations
  - Others
- Market Attractiveness, by End-user
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - China
  - Japan
  - India
  - Australia & New Zealand
  - Rest of Asia Pacific
- Market Attractiveness Analysis
  - By Product
  - By Mode
  - By Function
  - By End-user
  - By Country/Sub-region
Latin America Drug Discovery Informatics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product, 2021-2036
  - Discovery Informatics
  - Development Informatics
- Market Attractiveness, by Product
- Market Value Forecast, by Mode, 2021-2036
  - In-house Informatics
  - Outsourced Informatics
- Market Attractiveness, by Mode
- Market Value Forecast, by Function, 2021-2036
  - Sequencing and Target Data Analysis
  - Docking
  - Lead Generation Informatics
  - Identification and Validation Informatics
  - Molecular Modeling
  - Others
- Market Attractiveness, by Function
- Market Value Forecast, by End-user, 2021-2036
  - Pharmaceutical and Biotechnology Companies
  - Contract Research Organizations
  - Others
- Market Attractiveness, by End-user
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - Brazil
  - Mexico
  - Rest of Latin America
- Market Attractiveness Analysis
  - By Product
  - By Mode
  - By Function
  - By End-user
  - By Country/Sub-region
Middle East & Africa Drug Discovery Informatics Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Product, 2021-2036
  - Discovery Informatics
  - Development Informatics
- Market Attractiveness, by Product
- Market Value Forecast, by Mode, 2021-2036
  - In-house Informatics
  - Outsourced Informatics
- Market Attractiveness, by Mode
- Market Value Forecast, by Function, 2021-2036
  - Sequencing and Target Data Analysis
  - Docking
  - Lead Generation Informatics
  - Identification and Validation Informatics
  - Molecular Modeling
  - Others
- Market Attractiveness, by Function
- Market Value Forecast, by End-user, 2021-2036
  - Pharmaceutical and Biotechnology Companies
  - Contract Research Organizations
  - Others
- Market Attractiveness, by End-user
- Market Value Forecast, by Country/Sub-region, 2021-2036
  - GCC Countries
  - South Africa
  - Rest of Middle East & Africa
- Market Attractiveness Analysis
  - By Product
  - By Mode
  - By Function
  - By End-user
  - By Country/Sub-region
Competition Landscape
- Market Player - Competition Matrix (By Tier and Size of Companies)
- Market Share Analysis, by Company (2025)
- Company Profiles
  - Charles River Laboratories International, Inc.
    - Company Overview (HQ, Business Segments, Employee Strength)
    - Product Portfolio
    - Financial Overview
    - SWOT Analysis
    - Strategic Overview
  - Thermo Fisher Scientific, Inc.
    - Company Overview (HQ, Business Segments, Employee Strength)
    - Product Portfolio
    - Financial Overview
    - SWOT Analysis
    - Strategic Overview
  - Revvity, Inc.
    - Company Overview (HQ, Business Segments, Employee Strength)
    - Product Portfolio
    - Financial Overview
    - SWOT Analysis
    - Strategic Overview
  - Dotmatics
    - Company Overview (HQ, Business Segments, Employee Strength)
    - Product Portfolio
    - Financial Overview
    - SWOT Analysis
    - Strategic Overview
  - Dassault Systèmes SE / BIOVIA
    - Company Overview (HQ, Business Segments, Employee Strength)
    - Product Portfolio
    - Financial Overview
    - SWOT Analysis
    - Strategic Overview
  - Insilico Medicine, Inc.
    - Company Overview (HQ, Business Segments, Employee Strength)
    - Product Portfolio
    - Financial Overview
    - SWOT Analysis
    - Strategic Overview
  - Collaborative Drug Discovery, Inc. (CDD)
    - Company Overview (HQ, Business Segments, Employee Strength)
    - Product Portfolio
    - Financial Overview
    - SWOT Analysis
    - Strategic Overview
  - Schrödinger, Inc.
    - Company Overview (HQ, Business Segments, Employee Strength)
    - Product Portfolio
    - Financial Overview
    - SWOT Analysis
    - Strategic Overview
  - Curia Global, Inc.
    - Company Overview (HQ, Business Segments, Employee Strength)
    - Product Portfolio
    - Financial Overview
    - SWOT Analysis
    - Strategic Overview
  - Certara, Inc.
    - Company Overview (HQ, Business Segments, Employee Strength)
    - Product Portfolio
    - Financial Overview
    - SWOT Analysis
    - Strategic Overview

List of Tables

Table 01: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2021 to 2036
Table 02: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2021 to 2036
Table 03: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2021 to 2036
Table 04: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 05: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Region, 2021 to 2036
Table 06: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country, 2021 to 2036
Table 07: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2021 to 2036
Table 08: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2021 to 2036
Table 09: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2021 to 2036
Table 10: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 11: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2036
Table 12: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2021 to 2036
Table 13: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2021 to 2036
Table 14: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2021 to 2036
Table 15: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 16: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2036
Table 17: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2021 to 2036
Table 18: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2021 to 2036
Table 19: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2021 to 2036
Table 20: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 21: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2036
Table 22: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2021 to 2036
Table 23: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2021 to 2036
Table 24: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2021 to 2036
Table 25: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2021 to 2036
Table 26: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2036
Table 27: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2021 to 2036
Table 28: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Mode, 2021 to 2036
Table 29: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Function, 2021 to 2036
Table 30: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-user, 2021 to 2036

List of Figures

Figure 01: Global Drug Discovery Informatics Market Size (US$ Mn) and Distribution (%), by Region, 2025 and 2036
Figure 02: Global Drug Discovery Informatics Market Revenue (US$ Mn), by Product, 2025
Figure 03: Global Drug Discovery Informatics Market Value Share, by Product, 2025
Figure 04: Global Drug Discovery Informatics Market Revenue (US$ Mn), by Mode, 2025
Figure 05: Global Drug Discovery Informatics Market Value Share, by Mode, 2025
Figure 06: Global Drug Discovery Informatics Market Revenue (US$ Mn), by Function, 2025
Figure 07: Global Drug Discovery Informatics Market Value Share, by Function, 2025
Figure 08: Global Drug Discovery Informatics Market Value Share, by End-user, 2025
Figure 09: Global Drug Discovery Informatics Market Value Share, by End-user, 2025
Figure 10: Global Drug Discovery Informatics Market Value Share, by Region, 2025
Figure 11: Global Drug Discovery Informatics Market Value (US$ Mn) Forecast, 2021 to 2036
Figure 12: Global Drug Discovery Informatics Market Value Share Analysis, by Product, 2025 and 2036
Figure 13: Global Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2026-2036
Figure 14: Global Drug Discovery Informatics Market Value Share Analysis, by Mode, 2025 and 2036
Figure 15: Global Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2026-2036
Figure 16: Global Drug Discovery Informatics Market Value Share Analysis, by Function, 2025 and 2036
Figure 17: Global Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2026-2036
Figure 18: Global Drug Discovery Informatics Market Revenue (US$ Mn), by End-user, 2025
Figure 19: Global Drug Discovery Informatics Market Value Share, by End-user, 2025
Figure 20: Global Drug Discovery Informatics Market Value Share Analysis, by Region, 2025 and 2036
Figure 21: Global Drug Discovery Informatics Market Attractiveness Analysis, by Region, 2026-2036
Figure 22: North America Drug Discovery Informatics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2021 to 2036
Figure 23: North America Drug Discovery Informatics Market Attractiveness Analysis, by Country, 2026 to 2036
Figure 24: North America Drug Discovery Informatics Market Value Share Analysis, by Country, 2025 and 2036
Figure 25: North America Drug Discovery Informatics Market Value Share Analysis, by Product, 2025 and 2036
Figure 26: North America Drug Discovery Informatics Market Value Share Analysis, by Mode, 2025 and 2036
Figure 27: North America Drug Discovery Informatics Market Value Share Analysis, by Function, 2025 and 2036
Figure 28: North America Drug Discovery Informatics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 29: North America Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 30: North America Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2026 to 2036
Figure 31: North America Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2026 to 2036
Figure 32: North America Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 33: Europe Drug Discovery Informatics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2021 to 2036
Figure 34: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 35: Europe Drug Discovery Informatics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 36: Europe Drug Discovery Informatics Market Value Share Analysis, by Product, 2025 and 2036
Figure 37: Europe Drug Discovery Informatics Market Value Share Analysis, by Mode, 2025 and 2036
Figure 38: Europe Drug Discovery Informatics Market Value Share Analysis, by Function, 2025 and 2036
Figure 39: Europe Drug Discovery Informatics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 40: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 41: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2026 to 2036
Figure 42: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2026 to 2036
Figure 43: Europe Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 44: Asia Pacific Drug Discovery Informatics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2026 to 2036
Figure 45: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 46: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 47: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Product, 2025 and 2036
Figure 48: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Mode, 2025 and 2036
Figure 49: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Function, 2025 and 2036
Figure 50: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 51: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2021 to 2036
Figure 52: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2026 to 2036
Figure 53: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2026 to 2036
Figure 54: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 55: Latin America Drug Discovery Informatics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2021 to 2036
Figure 56: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 57: Latin America Drug Discovery Informatics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 58: Latin America Drug Discovery Informatics Market Value Share Analysis, by Product, 2025 and 2036
Figure 59: Latin America Drug Discovery Informatics Market Value Share Analysis, by Mode, 2025 and 2036
Figure 60: Latin America Drug Discovery Informatics Market Value Share Analysis, by Function, 2025 and 2036
Figure 61: Latin America Drug Discovery Informatics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 62: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 63: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2026 to 2036
Figure 64: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2026 to 2036
Figure 65: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 66: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2021 to 2036
Figure 67: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 68: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 69: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Product, 2025 and 2036
Figure 70: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Mode, 2025 and 2036
Figure 71: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Function, 2025 and 2036
Figure 72: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 73: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 74: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Mode, 2026 to 2036
Figure 75: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Function, 2026 to 2036
Figure 76: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by End-user, 2026 to 2036